Lili Gundelach wrote a new post 3 weeks, 3 days ago
Advancing Liver Cancer Care: Highlights from the BCLC 2024 Meeting
On November 25th and 26th, DiCE virtually attended the Barcelone Clinic Liver Cancer (BCLC) annual conference, which was titled “Forging a M […]-
Lili Gundelach wrote a new post 1 month, 3 weeks ago
Hepatocellular Carcinoma Prevention & Diagnosis: DiCE Publishes Project Results
Hepatocellular carcinoma (HCC, the most common form of liver cancer) is an often preventable disease with several treatment options available to […] -
Lili Gundelach wrote a new post 8 months ago
HCC Prevention and Diagnosis Mapping Survey
DiCE’s ongoing research project is aimed at mapping the status quo in the prevention and diagnosis of hepatocellular carcinoma (HCC) across the EU. […] -
Lili Gundelach wrote a new post 8 months ago
DiCE is a Partner in HoloSurge: a Horizon Grant-Winning Project on Holographic Surgical Planning
DiCE is a partner in the HoloSurge project, which was awarded a Horizon Europe grant to improve surgical planning with hologram technology One of […] -
Lili Gundelach wrote a new post 9 months ago
Extending the Liver Cancer Index: HCC Prevention and Diagnosis Mapping
DiCE is launching its research project to map the status quo in preventing and treating hepatocellular carcinoma (HCC) across the EU. Liver […] -
Lili Gundelach changed their profile picture 10 months ago
-
Lili Gundelach wrote a new post 10 months, 1 week ago
COR2ED’s New Resources on Advanced HCC
COR2ED is an independent medical education company that develops impactful educational programmes within specific therapeutic areas. They have […] -
Lili Gundelach wrote a new post 10 months, 1 week ago
ASCO GI Highlights – Positive Data in Earlier Stage HCC Results
The American Society for Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) was held in San Francisco, USA 18-20 January this year. At […] -
Lili Gundelach wrote a new post 1 year, 5 months ago
EU Commission Approval of Tibsovo® (Ivosidenib) in IDH1-mutated Cholangiocarcinoma
The European Commission approved the use of Tibsovo® (Ivosidenib) as monotherapy for the treatment of locally advanced or metastatic […] -
Lili Gundelach wrote a new post 1 year, 6 months ago
Liver Cancer Index – Data Gaps
DiCE would like to map liver cancer treatment across the EU. To achieve this, DiCE has started disseminating a survey this spring, primarily among […] -
Lili Gundelach wrote a new post 1 year, 6 months ago
Collaboration with COR2ED – HCC CONNECT
DiCE is pleased to collaborate with COR2ED, a provider of Independent Medical Education. To stay up-to-date in […] -
Lili Gundelach wrote a new post 1 year, 7 months ago
Highlights from the EASL Liver Cancer Summit
The European Association for the Study of the Liver (EASL) held the Liver Cancer Summit, its annual conference focused on liver cancer in Estoril, […]
